Why Vitamin C Serums Are Starting to Add Carnosine and Other Anti-Glycation Actives

Two different kinds of damage

Vitamin C earns its place in a routine as an antioxidant. It helps mop up free radicals, the unstable molecules produced by sunlight, pollution and ordinary metabolism, before they damage skin cells. That is one pathway of ageing, and it is the one almost every vitamin C serum is sold on.

Glycation is a separate pathway. Sugar molecules circulating in the body can attach themselves to proteins, and when that happens to structural proteins like collagen and elastin, the result is a stiffer, less elastic protein than the one you started with. The end products of that reaction are usually called advanced glycation end products. An antioxidant does not undo this, because it is not an oxidation reaction. That gap is what the newer formulas are aiming at.

What is actually being added

The clearest example is SkinCeuticals, which reworked C E Ferulic in 2026. The original formula was built on fifteen percent pure vitamin C as L-ascorbic acid, one percent vitamin E and half a percent ferulic acid. The next-generation version keeps all three at the same strengths and adds two things: carnosine at three tenths of a percent, and one percent of an ingredient the brand calls Endophytol, described as a biotechnology-derived dandelion root extract.

Carnosine is a small peptide built from two amino acids. SkinCeuticals says it helps protect supporting protein integrity and helps protect cellular proteostasis. Those are the brand's words, and they describe a mechanism rather than a measured outcome.

Vichy has taken a similar direction from a different starting point. Its reformulated LiftActiv serum, built on sixteen percent pure vitamin C, lists neohesperidin together with vitamin E as anti-glycation actives alongside hyaluronic acid.

Reading the evidence behind the claims

This is where it pays to slow down. SkinCeuticals launched the reformulation with a headline claim about visibly reversing years of ageing signs, and the supporting evidence is cited as clinical testing results held on file by the company. On file means not published, which means nobody outside the company can check the sample size, the duration, who did the grading, or whether there was a comparison group.

That is not an accusation of dishonesty. It is simply a weaker class of evidence than a published, peer-reviewed trial, and it should carry correspondingly less weight in a buying decision. The same applies to the ingredient descriptions above: a plausible mechanism for carnosine in a test tube is not the same claim as a measured improvement on a face.

Should this change what you buy?

Probably not by much, and certainly not on its own. Anti-glycation actives are an addition to an already crowded category, usually at fractions of a percent, and the things that decide whether a vitamin C serum does anything for you have not changed: which form of vitamin C it uses, at what strength, at a pH the formula can actually hold, in packaging that keeps air out, used consistently and followed by sunscreen.

If two serums are otherwise equal and one includes an anti-glycation active, it is a reasonable tiebreaker. It is not a reason to replace a serum that is working, and it is not a reason to pay substantially more. If you want to compare what is actually on the shelf, our serum listings carry current details, and the pH explainer covers the factor that affects results far more than any of these additions.